VRTX: Vertex Pharmaceuticals Incorporated Stocks News on December 20, 2024

VRTX

Morningstar Research

11 hours ago

Analyst Report: Vertex Pharmaceuticals Incorporated

S&P 500 Gains and Losses Today: Darden Restaurants Stock Sizzles After Sales Beat

VRTX

Investopedia

15 hours ago

S&P 500 Gains and Losses Today: Darden Restaurants Stock Sizzles After Sales Beat

Vertex Dives 11% On A 'Worst-Case Scenario' For Its Non-Opioid Pain Drug

VRTX

Investor's Business Daily

15 hours ago

Vertex Dives 11% On A 'Worst-Case Scenario' For Its Non-Opioid Pain Drug

VRTX

Insider Monkey

15 hours ago

Jim Cramer on Vertex Pharmaceuticals Incorporated (VRTX): ‘I Think You Should Buy The Dip Here’

VRTX

MT Newswires

17 hours ago

Oppenheimer Downgrades Vertex Pharmaceuticals to Market Perform From Outperform; Shares Fall

Why Is Vertex Pharmaceuticals Stock Trading Lower On Thursday After Back Pain Trial Data?

VRTX

Benzinga

18 hours ago

Why Is Vertex Pharmaceuticals Stock Trading Lower On Thursday After Back Pain Trial Data?

Accenture, Robinhood and Coinbase, Vertex: Market Minute

VRTX

Yahoo Finance Video

19 hours ago

Accenture, Robinhood and Coinbase, Vertex: Market Minute

VRTX

MT Newswires

19 hours ago

RBC Capital Cuts Vertex Pharmaceuticals' Price Target to $400 From $451

VRTX

MT Newswires

20 hours ago

Scotiabank Cuts Vertex Pharmaceuticals' Price Target to $426 From $486

Vertex Pain Drug Doesn’t Beat Placebo. The Company Says It Still Sees Promise.

VRTX

Barrons.com

21 hours ago

Vertex Pain Drug Doesn’t Beat Placebo. The Company Says It Still Sees Promise.

VRTX

Insider Monkey

a day ago

Here’s Why Vertex Pharmaceuticals Incorporated (VRTX) Slid in Q3

Vertex Plunges 10% After Its Non-Opioid Pain Drug Flops In Lower Back Pain

VRTX

Investor's Business Daily

a day ago

Vertex Plunges 10% After Its Non-Opioid Pain Drug Flops In Lower Back Pain

Vertex Non-Opioid Drug Doesn't Best Placebo In Back Pain Study. The Stock Is Plunging.

VRTX

Investor's Business Daily

a day ago

Vertex Non-Opioid Drug Doesn't Best Placebo In Back Pain Study. The Stock Is Plunging.

Vertex Announces Results From Phase 2 Study of Suzetrigine for the Treatment of Painful Lumbosacral Radiculopathy

VRTX

Business Wire

a day ago

Vertex Announces Results From Phase 2 Study of Suzetrigine for the Treatment of Painful Lumbosacral Radiculopathy

2 Unstoppable Stocks to Buy and Hold for the Next Decade

VRTX

Motley Fool

a day ago

2 Unstoppable Stocks to Buy and Hold for the Next Decade

VRTX

Zacks

2 days ago

Vertex Pharmaceuticals Incorporated (VRTX) Is a Trending Stock: Facts to Know Before Betting on It

4 Big Drug Stocks That May Continue to Outperform in 2025

VRTX

Zacks

3 days ago

4 Big Drug Stocks That May Continue to Outperform in 2025

VRTX

Zacks

4 days ago

Why Vertex Pharmaceuticals (VRTX) Outpaced the Stock Market Today

VRTX

Zacks

4 days ago

BMY vs. VRTX: Which Stock Is the Better Value Option?

VRTX

MT Newswires

4 days ago

Stifel Adjusts Price Target on Vertex Pharmaceuticals to $494 From $490, Maintains Hold Rating

Prediction: These Could Be the Best-Performing Pharma and Biotech Stocks Through 2030

VRTX

Motley Fool

4 days ago

Prediction: These Could Be the Best-Performing Pharma and Biotech Stocks Through 2030

VRTX

Motley Fool

5 days ago

3 Unstoppable Stocks to Buy Right Now

The Ultimate Biotech Stock to Buy With $500 Right Now

VRTX

Motley Fool

8 days ago

The Ultimate Biotech Stock to Buy With $500 Right Now

VRTX

Zacks

10 days ago

Vertex Pharmaceuticals (VRTX) Falls More Steeply Than Broader Market: What Investors Need to Know

Vertex Has $5 Billion-Plus Opportunity In Pain And Kidney Disease Programs, Analyst Upgrades Stock

VRTX

Benzinga

11 days ago

Vertex Has $5 Billion-Plus Opportunity In Pain And Kidney Disease Programs, Analyst Upgrades Stock

2 No-Brainer Stocks to Buy Before the End of 2024

VRTX

Motley Fool

11 days ago

2 No-Brainer Stocks to Buy Before the End of 2024

VRTX

MT Newswires

11 days ago

Jefferies Upgrades Vertex Pharmaceuticals to Buy From Hold, Adjusts Price Target to $550 From $500

Gene therapy uptake in sickle cell stays slow, despite patient interest

VRTX

BioPharma Dive

11 days ago

Gene therapy uptake in sickle cell stays slow, despite patient interest

Vertex Presents Positive Long-Term Data On CASGEVY™ (exagamglogene autotemcel) at the American Society of Hematology (ASH) Annual Meeting and Exposition and Provides Program Update

VRTX

Business Wire

12 days ago

Vertex Presents Positive Long-Term Data On CASGEVY™ (exagamglogene autotemcel) at the American Society of Hematology (ASH) Annual Meeting and Exposition and Provides Program Update

3 No-Brainer Growth Stocks to Buy in December

VRTX

Motley Fool

13 days ago

3 No-Brainer Growth Stocks to Buy in December

Should You Forget Pfizer and Buy These Unstoppable Stocks Instead?

VRTX

Motley Fool

15 days ago

Should You Forget Pfizer and Buy These Unstoppable Stocks Instead?

3 of the Best Growth Stocks You Can Buy for Less than $100

VRTX

Motley Fool

15 days ago

3 of the Best Growth Stocks You Can Buy for Less than $100

VRTX

Zacks

16 days ago

Why Is Vertex (VRTX) Down 8.6% Since Last Earnings Report?

VRTX

Zacks

16 days ago

Investors Heavily Search Vertex Pharmaceuticals Incorporated (VRTX): Here is What You Need to Know

Meet the Beaten-Down Biotech Stock Cathie Wood Loves and Wall Street Says May Soar More than 65%

VRTX

Motley Fool

20 days ago

Meet the Beaten-Down Biotech Stock Cathie Wood Loves and Wall Street Says May Soar More than 65%

VRTX

Zacks

21 days ago

GILD vs. VRTX: Which Stock Should Value Investors Buy Now?

US Exchange Highlights 3 Stocks Possibly Trading Below Intrinsic Value

VRTX

Simply Wall St.

21 days ago

US Exchange Highlights 3 Stocks Possibly Trading Below Intrinsic Value

Want $1 Million in Retirement? 3 Stocks to Buy Now and Hold for Decades.

VRTX

Motley Fool

22 days ago

Want $1 Million in Retirement? 3 Stocks to Buy Now and Hold for Decades.

High Growth Tech Stocks to Watch in November 2024

VRTX

Simply Wall St.

23 days ago

High Growth Tech Stocks to Watch in November 2024

VRTX

Simply Wall St.

25 days ago

Vertex Pharmaceuticals (NASDAQ:VRTX) shareholders are still up 137% over 3 years despite pulling back 3.4% in the past week

Down 47% Since March, Is CRISPR Therapeutics Stock a Buy on the Dip?

VRTX

Motley Fool

a month ago

Down 47% Since March, Is CRISPR Therapeutics Stock a Buy on the Dip?

VRTX

Motley Fool

a month ago

3 Monster Stocks in the Making

VRTX

MT Newswires

a month ago

Wolfe Research Raises Price Target on Vertex Pharmaceuticals to $538 From $518, Maintains Outperform Rating

VRTX

Insider Monkey

a month ago

Goldman Sachs: Vertex Pharmaceuticals Incorporated (VRTX) Is A Top Growth Investor Stock

Got $500? 1 Biotech Stock to Buy and Hold Forever

VRTX

Motley Fool

a month ago

Got $500? 1 Biotech Stock to Buy and Hold Forever

VRTX

MT Newswires

a month ago

Redburn Atlantic Adjusts Vertex Pharmaceuticals Price Target to $570 From $560

VRTX

Simply Wall St.

a month ago

Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) Shares Could Be 48% Below Their Intrinsic Value Estimate

VRTX

Zacks

a month ago

Vertex Pharmaceuticals Incorporated (VRTX) is Attracting Investor Attention: Here is What You Should Know

3 Growth Stocks You Can Buy Right Now Without Any Hesitation

VRTX

Motley Fool

a month ago

3 Growth Stocks You Can Buy Right Now Without Any Hesitation

Prediction: This Biotech Stock Is Heading for a Once-in-a-Generation Opportunity

VRTX

Motley Fool

a month ago

Prediction: This Biotech Stock Is Heading for a Once-in-a-Generation Opportunity

VRTX

Zacks

a month ago

GILD or VRTX: Which Is the Better Value Stock Right Now?

Five S&P 500 Stocks On This Elite IBD List Near Buy Points

VRTX

Investor's Business Daily

a month ago

Five S&P 500 Stocks On This Elite IBD List Near Buy Points

Stock Market: Three Top Names In Buy Zones, One With Earnings Due

VRTX

Investor's Business Daily

a month ago

Stock Market: Three Top Names In Buy Zones, One With Earnings Due

2 Biotech Stocks You Can Buy Hand Over Fist This Month

VRTX

Motley Fool

a month ago

2 Biotech Stocks You Can Buy Hand Over Fist This Month

VRTX

Zacks

a month ago

Vertex Pharmaceuticals Incorporated (VRTX) Is a Trending Stock: Facts to Know Before Betting on It

VRTX

MT Newswires

a month ago

Argus Raises Price Target on Vertex Pharmaceuticals to $550 From $530

VRTX

Argus Research

a month ago

Market Update: ENB, MCHP, VRTX, XOM, YUM, GNRC, RITM

VRTX

Argus Research

a month ago

Analyst Report: Vertex Pharmaceuticals, Inc.

VRTX

Zacks

a month ago

Vertex Pharmaceuticals (VRTX) Just Overtook the 20-Day Moving Average

VRTX

Zacks

a month ago

Vertex Pharmaceuticals (VRTX) Crossed Above the 50-Day Moving Average: What That Means for Investors

Vertex Pharmaceuticals Third Quarter 2024 Earnings: Beats Expectations

VRTX

Simply Wall St.

a month ago

Vertex Pharmaceuticals Third Quarter 2024 Earnings: Beats Expectations

Moderna said to shuffle sales leadership; Vertex records first Casgevy sale

VRTX

BioPharma Dive

a month ago

Moderna said to shuffle sales leadership; Vertex records first Casgevy sale

VRTX

Morningstar Research

a month ago

Analyst Report: Vertex Pharmaceuticals Incorporated

VRTX

Zacks

a month ago

Vertex (VRTX) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates

Vertex Flashes A Surprise Buy Point As Non-Opioid Pain Drug Looms

VRTX

Investor's Business Daily

a month ago

Vertex Flashes A Surprise Buy Point As Non-Opioid Pain Drug Looms

Vertex shares up after full-year product revenue guidance boost

VRTX

Pharmaceutical Technology

a month ago

Vertex shares up after full-year product revenue guidance boost

VRTX

MT Newswires

a month ago

UBS Raises Price Target on Vertex Pharmaceuticals to $586 From $562, Maintains Buy Rating

VRTX

Zacks

a month ago

VRTX Q3 Earnings & Sales Trump Estimates, '24 Sales View Raised

VRTX

MT Newswires

a month ago

RBC Capital Adjusts Vertex Pharmaceuticals Price Target to $451 From $437, Maintains Sector Perform Rating

VRTX

Motley Fool

a month ago

5 Top Stocks to Buy in November

VRTX

Thomson Reuters StreetEvents

a month ago

Q3 2024 Vertex Pharmaceuticals Inc Earnings Call

VRTX

MT Newswires

a month ago

Morgan Stanley Adjusts Price Target on Vertex Pharmaceuticals to $476 From $473, Maintains Equalweight Rating

VRTX

MT Newswires

a month ago

Scotiabank Adjusts Price Target on Vertex Pharmaceuticals to $486 From $480, Maintains Sector Perform Rating

VRTX

MT Newswires

a month ago

Bernstein Adjusts Price Target on Vertex Pharmaceuticals to $506 From $502, Maintains Market Perform Rating

VRTX

MT Newswires

a month ago

Goldman Sachs Adjusts Price Target on Vertex Pharmaceuticals to $602 From $598, Maintains Buy Rating

VRTX

MT Newswires

a month ago

JPMorgan Adjusts Price Target on Vertex Pharmaceuticals to $503 From $510, Maintains Overweight Rating

VRTX

GuruFocus.com

a month ago

Vertex Pharmaceuticals Inc (VRTX) Q3 2024 Earnings Call Highlights: Strong Revenue Growth and ...

VRTX

Motley Fool

a month ago

Vertex Pharmaceuticals (VRTX) Q3 2024 Earnings Call Transcript

Vertex Beats Expectations, But Needs More To Drive 'Another Leg Of Stock Upside'

VRTX

Investor's Business Daily

2 months ago

Vertex Beats Expectations, But Needs More To Drive 'Another Leg Of Stock Upside'

VRTX

Zacks

2 months ago

Vertex Pharmaceuticals (VRTX) Q3 Earnings and Revenues Top Estimates

Vertex Pharmaceuticals Beats Third-Quarter Estimates As Pain Treatment Looms

VRTX

Investor's Business Daily

2 months ago

Vertex Pharmaceuticals Beats Third-Quarter Estimates As Pain Treatment Looms

VRTX

MT Newswires

2 months ago

Vertex Pharmaceuticals Q3 Non-GAAP Profit, Revenue Rise; 2024 Revenue Outlook Updated

VRTX

Associated Press Finance

2 months ago

Vertex: Q3 Earnings Snapshot

Vertex Pharma lifts annual revenue forecast on cystic fibrosis treatments strength

VRTX

Reuters

2 months ago

Vertex Pharma lifts annual revenue forecast on cystic fibrosis treatments strength

Vertex Reports Third Quarter 2024 Financial Results

VRTX

Business Wire

2 months ago

Vertex Reports Third Quarter 2024 Financial Results

US Stocks That May Be Trading Below Estimated Value In October 2024

VRTX

Simply Wall St.

2 months ago

US Stocks That May Be Trading Below Estimated Value In October 2024

VRTX

Zacks

2 months ago

Why the Market Dipped But Vertex Pharmaceuticals (VRTX) Gained Today

VRTX

MT Newswires

2 months ago

Oppenheimer Adjusts Price Target on Vertex Pharmaceuticals to $540 From $550

Vertex to Participate in Upcoming November Investor Conferences

VRTX

Business Wire

2 months ago

Vertex to Participate in Upcoming November Investor Conferences

Vertex Gears Up to Report Q3 Earnings: Is a Beat in the Cards?

VRTX

Zacks

2 months ago

Vertex Gears Up to Report Q3 Earnings: Is a Beat in the Cards?

Earnings Preview: IDEAYA Biosciences, Inc. (IDYA) Q3 Earnings Expected to Decline

VRTX

Zacks

2 months ago

Earnings Preview: IDEAYA Biosciences, Inc. (IDYA) Q3 Earnings Expected to Decline

VRTX

Zacks

2 months ago

Vertex Pharmaceuticals (VRTX) Stock Drops Despite Market Gains: Important Facts to Note

VRTX

Zacks

2 months ago

Vertex Pharmaceuticals (VRTX) Earnings Expected to Grow: What to Know Ahead of Next Week's Release

The Ultimate Biotech Stock to Buy With $50 Right Now

VRTX

Motley Fool

2 months ago

The Ultimate Biotech Stock to Buy With $50 Right Now

Vertex Provides Updates on Multiple Kidney Programs at the American Society of Nephrology (ASN) Annual Kidney Week Congress

VRTX

Business Wire

2 months ago

Vertex Provides Updates on Multiple Kidney Programs at the American Society of Nephrology (ASN) Annual Kidney Week Congress

VRTX

Simply Wall St.

2 months ago

Recent 5.4% pullback isn't enough to hurt long-term Vertex Pharmaceuticals (NASDAQ:VRTX) shareholders, they're still up 159% over 3 years

The Smartest Growth Stock to Buy With $500 Right Now

VRTX

Motley Fool

2 months ago

The Smartest Growth Stock to Buy With $500 Right Now

Vertex Pharmaceuticals Just Found Its Newest Blockbuster Drug. A $41 Billion Market Awaits

VRTX

Motley Fool

2 months ago

Vertex Pharmaceuticals Just Found Its Newest Blockbuster Drug. A $41 Billion Market Awaits

How to Boost Your Portfolio with Top Medical Stocks Set to Beat Earnings

VRTX

Zacks

2 months ago

Latest Vertex Pharmaceuticals Incorporated (VRTX) News on December 20, 2024

Share on Social Networks: